ANI Pharmaceuticals | ANIP - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
AbbVie USD 4.29B 73M 2026-06
ANI Pharmaceuticals USD 119.8M 5.3M 2026-06
Aurora Cannabis CAD 8.22M 80.38M 2026-03
Canopy Growth CAD 62.98M 9.91M 2026-03
Eli Lilly USD 3.27B 309M 2026-06
Emergent BioSolutions USD 381.2M 226.1M 2023-06
Heron Therapeutics USD 11.12M 795K 2025-12
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Novartis USD 3.46B 83M 2026-03
Omeros USD 33.16M 18.52M 2024-06
Perrigo USD 708.9M 65.2M 2026-06
Sun Pharmaceuticals INR 37.02B 9.01B 2026-06
Teva Pharmaceutical Industries USD 1.98B 30M 2026-06